This site is intended for health professionals only
Sunday 26 May 2019
Share |

EMA publishes human drugs under evaluation

The European Medicines Agency has published a list of all new human medicines under evaluation by the Committee for Medicinal Products for Human Use (CHMP). 

The list includes the international non-proprietary names (INNs) and therapeutic areas for all new innovative medicines under evaluation, along with information on the type of salt, ester or derivative of the active substance. 

For generic and biosimilar medicines, it includes the INN and therapeutic area. The list only includes medicines whose applications have been validated.

The Agency will update this information every month following the plenary meeting of the CHMP.

This initiative forms part of the drive towards increased transparency on its activities by the Agency and other European regulatory authorities. It follows the publication of recommendations on transparency of ongoing evaluations adopted by the European Medicines Agency and the Heads of Medicines Agencies in November 2010.

INNs or generic names are the globally recognised names used to identify active ingredients in pharmaceuticals. INNs are selected by the World Health Organisation (WHO).

European Medicines Agency

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher